Successful treatment of recalcitrant juvenile pemphigus foliaceus with intravenous immunoglobulin and rituximab

Pemphigus foliaceus (PF) is uncommon among children. The usage of rituximab in childhood PF is even less documented. We reported a case of a 16-year-old boy with juvenile PF who failed conventional treatments and was started on combination therapy of intravenous immunoglobulin (IVIG) and rituximab f...

Full description

Bibliographic Details
Main Authors: Hock Gin Teo, Tzyy Huei Lim, Kin Fon Leong, Pubalan Muniandy
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2022-01-01
Series:Indian Journal of Paediatric Dermatology
Subjects:
Online Access:http://www.ijpd.in/article.asp?issn=2319-7250;year=2022;volume=23;issue=3;spage=245;epage=248;aulast=Teo